CAMARGO PHARMACEUTICAL SERVICES
Camargo Pharmaceutical Services provides comprehensive drug development services specialized for the 505(b)(2) approval pathway and analogous European processes.
CAMARGO PHARMACEUTICAL SERVICES
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2003-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.camargopharma.com
Total Employee:
51+
Status:
Active
Contact:
513) 561-3329
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS Google Google Cloud
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-02 | Paidion Research | Paidion Research acquired by Camargo Pharmaceutical Services | N/A |
Official Site Inspections
http://www.camargopharma.com
- Host name: 182.202.202.35.bc.googleusercontent.com
- IP address: 35.202.202.182
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Camargo Pharmaceutical Services"
Premier Research Acquires Camargo Pharmaceutical Services - PR …
May 18, 2021 As a full-service clinical research and development organization, Premier provides all the capabilities Camargo needs to step up long-term growth strategies. ... Visit …See details»
Premier Research Acquires Camargo Pharmaceutical Services
May 18, 2021 “Premier Research’s well-deserved reputation and strength in assisting its customers, particularly in rare disease and oncology, will help accelerate our combined growth …See details»
Premier Research Acquires Camargo Pharmaceutical Services
May 18, 2021 As a full-service clinical research and development organization, Premier provides all the capabilities Camargo needs to step up long-term growth strategies. ... Visit …See details»
Ken Phelps - President, Co-Founder - LinkedIn
President, Co-Founder at Camargo Pharmaceutical Services · In 2003, I utilized more than three decades of experience in the health science and services industry to found Camargo …See details»
Camargo Pharmaceutical Services - CRO Database - ICH GCP
Contract research organizations; Camargo Pharmaceutical Services; Camargo Pharmaceutical Services. Phone: (513) 561-3329 (888) 451-5708 Fax: (513) 561-3367 E-mail: …See details»
Camargo Pharmaceutical Services - PitchBook
Sep 12, 2007 Information on acquisition, funding, investors, and executives for Camargo Pharmaceutical Services. Use the PitchBook Platform to explore the full profile.See details»
Camargo Pharmaceutical Services acquires Paidion Research
Mar 2, 2021 Camargo has experience in complex development programs and accelerated approval pathways that leverage our core expertise in areas such as oncology, pediatrics, rare …See details»
Camargo Pharmaceutical Services To Expand Capabilities And …
CINCINNATI, Feb. 26, 2019 /PRNewswire/ -- Camargo Pharmaceutical Services, an industry-leading drug development and commercialization services company, today announced it will …See details»
Camargo Pharmaceutical Services - VentureRadar
Similar Companies: Syngene (Biocon) India n/a Syngene is an innovation-led contract research, development, and manufacturing organization offering integrated scientific services from early …See details»
Camargo Pharmaceutical Services Enhances Drug Development
Jun 13, 2019 Founded in 2005, InSymbiosis is managed by seasoned ex-pharma and contract research organization drug development scientists and executives. Based in Montreal, …See details»
Daniel S. Duffy - Appointed New CEO of Camargo ... - Markets …
CINCINNATI, April 30, 2018 /PRNewswire/ -- Camargo Pharmaceutical Services, LLC, ("Camargo") the global leader in 505(b)(2) drug development and global equivalents, today …See details»
Camargo Pharmaceutical Services Acquires Paidion Research
CINCINNATI, Mar. 2, 2021 /PRNewswire/ -- Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, …See details»
Camargo Pharmaceutical Services Acquires Paidion Research - PR …
CINCINNATI, Mar. 2, 2021 /PRNewswire/ -- Camargo Pharmaceutical Services, LLC, a leading drug development and commercial partner, announced today it will acquire Paidion Research, …See details»
Olu Aloba Joins Camargo Pharmaceutical Services as Senior …
Mar 14, 2014 CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, strengthens its …See details»
Daniel S. Duffy - Appointed New CEO of Camargo Pharmaceutical …
CINCINNATI, April 30, 2018 /PRNewswire/ -- Camargo Pharmaceutical Services, LLC, ("Camargo") the global leader in 505(b)(2) drug development and global equivalents, today …See details»
FOR IMMEDIATE RELEASE - Camargo
As head of a full-service organization specializing in 505(b)(2) development, Phelps stressed the importance of careful planning to evaluate both the scientific, regulatory and ...See details»
WHY MORE DRUGS THAN EVER ARE APPROVED THROUGH …
Www.camargopharma.com This path allows companies to get out of the competitive environment of generics while still enjoying a development process that eliminates most preclinical studies …See details»
THE 505(B)(2) APPROVAL PATHWAY PROVIDES OPPORTUNITIES …
Www.camargopharma.com each subsequent drug modification. Lower costs for development of niche products and their approval provide improved ROI for 505(b)(2) drugs compared to …See details»
Camargo Pharmaceutical Services Enhances Drug Development …
CINCINNATI, June 13, 2019 /PRNewswire/ -- Camargo Pharmaceutical Services, a leading drug development and commercialization partner, announced today it will acquire InSymbiosis, a …See details»
Understanding the 505(b)(2) Approval Pathway - Camargo
Overview A 505(b)(2) is a new drug application which contains full safety and efectiveness reports, but allows at least some of the information required forSee details»